The deep research logic is organized as follows:
Okay, let's tackle this question about Regencell Bioscience's stock split. The user is asking when the stock split will happen. First, I need to check the references provided.
Looking at the references, there are several mentions of a 38-for-1 forward stock split. The key dates mentioned are the record date on June 12, 2025, distribution on June 13, and trading on a post-split basis starting June 16, 2025. However, the user is specifically asking about the ex-split date, which is the date when the stock starts trading at the split-adjusted price.
In the references, there's a query result (Number 19) that mentions the ex-split date as 20250616, which is June 16, 2025. This aligns with the information from the press releases and other articles. The stock split is expected to be effective on this date, pending Nasdaq approval.
I should also consider the user's profile. They're interested in technical analysis and short-term investments, so mentioning the impact on trading and liquidity might be relevant. However, the question is straightforward about the timing, so the focus should be on the specific dates provided in the references.
I need to make sure the answer is clear and cites the correct references. The user might be looking to adjust their trading strategies around these dates, so providing the exact dates and their implications is crucial. Also, since the user prefers concise and data-driven answers, structuring the response with a table and key dates would be effective.
I should also check if there are any conflicting dates in the references. All the relevant sources point to June 16 as the effective date, so there's consistency there. The record date is June 12, and the distribution is June 13, but the ex-split date is June 16.
Finally, I need to ensure that the answer doesn't include any unsupported information. The user's question is about when the split happens, so focusing on the ex-split date and the surrounding dates is appropriate. No need to delve into the reasons behind the split unless the user asks for it, which they didn't in this case.
Conclusion
The Regencell Bioscience (RGC) stock split will take effect on June 16, 2025 12. This date marks the start of trading on a post-split basis, following the record date (June 12, 2025) and distribution date (June 13, 2025). Below is a detailed breakdown of the timeline and implications for investors:
Stock Split Timeline
| Event |
Date |
Details |
| Record Date |
June 12, 2025 |
Shareholders of record at market close will receive 37 additional shares per share held 42. |
| Distribution Date |
June 13, 2025 |
Additional shares will be distributed to shareholders 42. |
| Ex-Split Date |
June 16, 2025 |
Trading begins on a post-split adjusted basis 12. |
Key Implications
- Liquidity Boost: The 38-for-1 split aims to lower the price per share, making RGC more accessible to retail investors and increasing market liquidity 56.
- No Action Required: Shareholders holding through brokers will see their positions automatically adjusted 42.
- Price Adjustment: Post-split, the stock price will reflect the 38-for-1 ratio, with no changes to the company’s name, CUSIP, or trading symbol 42.
Why This Matters for You
As a short-term investor focused on technical analysis, the stock split could create opportunities for price volatility and potential short squeezes, especially given RGC’s recent speculative rally (e.g., a 14,899% YTD gain in 2025) 78. The lower price post-split may attract new retail interest, aligning with your preference for news-driven strategies.
6/5/2025 11:03am
